Zobrazeno 1 - 10
of 194
pro vyhledávání: '"Bennie H Jeng"'
Autor:
Thomas M Lietman, Jennifer Rose-Nussbaumer, Bennie H Jeng, Benjamin F Arnold, Winston Chamberlain, Ellen H Koo, Zeba A Syed, Jonathan Lass, Charles C Lin, Jennifer Y Li, William Gensheimer, Jameson Clover, Nicole Varnado, Sarah Abdelrahman, Beth Ann Benetz, Amrita Srinivasan
Publikováno v:
BMJ Open Ophthalmology, Vol 9, Iss 1 (2024)
Introduction It remains uncertain whether Descemet membrane endothelial keratoplasty (DMEK) or Descemet stripping only (DSO) yields better outcomes in patients with symptomatic Fuchs endothelial corneal dystrophy (FECD). This paper presents the proto
Externí odkaz:
https://doaj.org/article/3bf3c5b14130429dae448403754ab4c0
Autor:
Thomas M Lietman, Jennifer Rose-Nussbaumer, Bennie H Jeng, Benjamin F Arnold, Winston Chamberlain, Charles C Lin, Jennifer Y Li, William Gensheimer, Jameson Clover, Nicole Varnado, Sarah Abdelrahman
Publikováno v:
BMJ Open Ophthalmology, Vol 9, Iss 1 (2024)
Background It remains uncertain which endothelial keratoplasty (EK) technique yields the best outcomes while maintaining safety, particularly in eyes with coexisting ocular conditions. Moreover, the impact of endothelial cell loss (ECL) on long-term
Externí odkaz:
https://doaj.org/article/55bde09c4aef4fe4a41114c1dd148e1b
Autor:
Francisco C Figueiredo, Conor C Murphy, Vito Romano, Lucas M Bachmann, Bennie H Jeng, Michael A Thiel, Katja C Iselin, Philipp B Baenninger, Sayali P Pradhan, Vishal Vohra, Claude Kaufmann
Publikováno v:
BMJ Open Ophthalmology, Vol 8, Iss 1 (2023)
Background/aims The objective of this multicentre, multinational, prospective study was to assess the level of basic understanding that individuals with keratoconus possessed about their condition.Methods We recruited 200 active keratoconus patients
Externí odkaz:
https://doaj.org/article/4ed17e5a413c47478d1956df3c045267
Autor:
Bennie H Jeng
Publikováno v:
Taiwan Journal of Ophthalmology, Vol 13, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/21ff50463bca43f4b795222012f50501
Autor:
Muhammad Ali, MBBS, David Glasser, MD, Bennie H. Jeng, MD, Jonathan H. Lass, MD, Brian Philippy, BS, CEBT, Divya Srikumaran, MD
Publikováno v:
Ophthalmology Science, Vol 2, Iss 3, Pp 100177- (2022)
Externí odkaz:
https://doaj.org/article/9d9ffb42d09843a595b8cc32407f10d5
Autor:
Sagar Lonial, Ajay K. Nooka, Praneetha Thulasi, Ashraf Z. Badros, Bennie H. Jeng, Natalie S. Callander, Heather A. Potter, Douglas Sborov, Brian E. Zaugg, Rakesh Popat, Simona Degli Esposti, Julie Byrne, Joanna Opalinska, January Baron, Trisha Piontek, Ira Gupta, Reza Dana, Asim V. Farooq, Kathryn Colby, Andrzej Jakubowiak
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-11 (2021)
Abstract Belantamab mafodotin (belamaf) demonstrated deep and durable responses in patients with heavily pretreated relapsed or refractory multiple myeloma (RRMM) in DREAMM-2 (NCT03525678). Corneal events, specifically keratopathy (including superfic
Externí odkaz:
https://doaj.org/article/f4fbded7918448a587750cd9f85b8f33
Autor:
Asim V. Farooq, Simona Degli Esposti, Rakesh Popat, Praneetha Thulasi, Sagar Lonial, Ajay K. Nooka, Andrzej Jakubowiak, Douglas Sborov, Brian E. Zaugg, Ashraf Z. Badros, Bennie H. Jeng, Natalie S. Callander, Joanna Opalinska, January Baron, Trisha Piontek, Julie Byrne, Ira Gupta, Kathryn Colby
Publikováno v:
Ophthalmology and Therapy, Vol 9, Iss 4, Pp 889-911 (2020)
Abstract Introduction Patients with relapsed or refractory multiple myeloma (RRMM) represent an unmet clinical need. Belantamab mafodotin (belamaf; GSK2857916) is a first-in-class antibody–drug conjugate (ADC; or immunoconjugate) that delivers a cy
Externí odkaz:
https://doaj.org/article/c9f8e5b32350407bb7943466355dff73
Autor:
MeeLee Tom, Elisabeth J. Cohen, Carlos LopezJimenez, Judith S. Hochman, Andrea B. Troxel, Bennie H. Jeng
Publikováno v:
Contemporary Clinical Trials Communications, Vol 24, Iss , Pp 100875- (2021)
Purpose: To describe steps taken that enabled a high rate of retention and early resumption of enrollment in the Zoster Eye Disease Study (ZEDS), a randomized controlled trial funded by the National Eye Institute, during the first 13 months (3/1/2020
Externí odkaz:
https://doaj.org/article/a96e9cb1ebe84e4f8b3436cf3f183e2c
Autor:
Asim V. Farooq, Simona Degli Esposti, Rakesh Popat, Praneetha Thulasi, Sagar Lonial, Ajay K. Nooka, Andrzej Jakubowiak, Douglas Sborov, Brian E. Zaugg, Ashraf Z. Badros, Bennie H. Jeng, Natalie S. Callander, Joanna Opalinska, January Baron, Trisha Piontek, Julie Byrne, Ira Gupta, Kathryn Colby
Publikováno v:
Ophthalmology and Therapy, Vol 9, Iss 4, Pp 913-915 (2020)
The authors of the above mentioned article would like to highlight the following corrections, based upon recent changes to the FDA label and guidance on the use of belamaf
Externí odkaz:
https://doaj.org/article/71703d0b771d43d492eca3051569effb
Publikováno v:
Cornea. 42:731-738
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bd9c727764593eca2e1dab9ce5aecd1
https://doi.org/10.1097/ico.0000000000003246
https://doi.org/10.1097/ico.0000000000003246